Risk of Bacteriophage Therapeutics to Transfer Genetic Material and Contain Contaminants Beyond Endotoxins with Clinically Relevant Mitigation Strategies

References

• Doub JB, Ng VY, Johnson A, Amoroso A, Kottilil S, Wilson E. Potential use of adjuvant bacteriophage therapy with debridement, antibiotics, and implant retention surgery to treat chronic prosthetic joint infections. Open Forum Infect Dis. 2021;8(6):ofab277. doi:10.1093/ofid/ofab27734159220
   PubMed Web of Science ®Google Scholar
• Trend S, Fonceca AM, Ditcham WG, Kicic A, Cf A. The potential of phage therapy in cystic fibrosis: essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways. J Cyst Fibros. 2017;16(6):663–670. doi:10.1016/j.jcf.2017.06.01228720345
   PubMed Web of Science ®Google Scholar
• Dickey J, Perrot V, Becker K. Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro. PLoS One. 2019;14(1):e0209390. doi:10.1371/journal.pone.020939030650088
   PubMed Web of Science ®Google Scholar
• Yilmaz C, Colak M, Yilmaz BC, Ersoz G, Kutateladze M, Gozlugol M. Bacteriophage therapy in implant-related infections: an experimental study. J Bone Joint Surg Am. 2013;95(2):117–125. doi:10.2106/JBJS.K.0113523324958
   PubMed Web of Science ®Google Scholar
• Chaudhry WN, Concepción-Acevedo J, Park T, Andleeb S, Bull JJ, Levin BR. Synergy and order effects of antibiotics and phages in killing pseudomonas aeruginosa biofilms. PLoS One. 2017;12(1):e0168615. doi:10.1371/journal.pone.016861528076361
   PubMed Web of Science ®Google Scholar
• Kaur S, Harjai K, Chhibber S. Bacteriophage mediated killing of Staphylococcus aureus in vitro on orthopaedic K wires in presence of linezolid prevents implant colonization. PLoS One. 2014;9:e90411. doi:10.1371/journal.pone.009041124594764
   PubMed Web of Science ®Google Scholar
• Ferry T, Kolenda C, Batailler C, et al. Phage therapy as adjuvant to conservative surgery and antibiotics to salvage patients with relapsing S. aureus prosthetic knee infection. Front Med (Lausanne). 2020;7:570572. doi:10.3389/fmed.2020.57057233304911
   PubMed Web of Science ®Google Scholar
• Onsea J, Soentjens P, Djebara S, et al. Bacteriophage application for difficult-to-treat musculoskeletal infections: development of a standardized multidisciplinary treatment protocol. Viruses. 2019;11(10):891. doi:10.3390/v11100891
   Web of Science ®Google Scholar
• Aslam S, Lampley E, Wooten D, et al. Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States. Open Forum Infect Dis. 2020;7(9):ofaa389. doi:10.1093/ofid/ofaa38933005701
   PubMed Web of Science ®Google Scholar
• Doub JB. Bacteriophage therapy for clinical biofilm infections: parameters that influence treatment protocols and current treatment approaches. Antibiotics (Basel). 2020;9(11):799. doi:10.3390/antibiotics9110799
   Web of Science ®Google Scholar
• Jault P, Leclerc T, Jennes S, et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind Phase 1/2 trial. Lancet Infect Dis. 2019;19(1):35–45. doi:10.1016/S1473-3099(18)30482-130292481
   PubMed Web of Science ®Google Scholar
• Leitner L, Ujmajuridze A, Chanishvili N, et al. Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial. Lancet Infect Dis. 2021;21(3):427–436. doi:10.1016/S1473-3099(20)30330-332949500
   PubMed Web of Science ®Google Scholar
• Rhoads DD, Wolcott RD, Kuskowski MA, Wolcott BM, Ward LS, Sulakvelidze A. Bacteriophage therapy of venous leg ulcers in humans: results of a Phase I safety trial. J Wound Care. 2009;18(6):237–243. doi:10.12968/jowc.2009.18.6.4280119661847
   PubMedGoogle Scholar
• Mašlaňová I, Doškař J, Varga M, et al. Bacteriophages of Staphylococcus aureus efficiently package various bacterial genes and mobile genetic elements including SCCmec with different frequencies. Environ Microbiol Rep. 2013;5(1):66–73. doi:10.1111/j.1758-2229.2012.00378.x23757132
   PubMed Web of Science ®Google Scholar
• Birge EA. Bacterial and Bacteriophage Genetics. 4th ed. New York: Springer; 2000.
   Google Scholar
• Goh S. Phage Transduction. Methods Mol Biol. 2016;1476:177–185.27507341
   PubMedGoogle Scholar
• Chen J, Quiles-Puchalt N, Chiang YN, et al. Genome hypermobility by lateral transduction. Science. 2018;362(6411):207–212. doi:10.1126/science.aat586730309949
   PubMed Web of Science ®Google Scholar
• Volkova VV, Lu Z, Besser T, Gröhn YT. Modeling the infection dynamics of bacteriophages in enteric Escherichia coli: estimating the contribution of transduction to antimicrobial gene spread. Appl Environ Microbiol. 2014;80(14):4350–4362. doi:10.1128/AEM.00446-1424814786
   PubMed Web of Science ®Google Scholar
• Nanda AM, Thormann K, Frunzke J. Impact of spontaneous prophage induction on the fitness of bacterial populations and host-microbe interactions. J Bacteriol. 2015;197(3):410–419. doi:10.1128/JB.02230-1425404701
   PubMed Web of Science ®Google Scholar
• Chiang YN, Penadés JR, Chen J. Genetic transduction by phages and chromosomal islands: the new and noncanonical. PLoS Pathog. 2019;15:e1007878. doi:10.1371/journal.ppat.100787831393945
   PubMed Web of Science ®Google Scholar
• Fillol-Salom A, Alsaadi A, Sousa JAM, et al. Bacteriophages benefit from generalized transduction. PLoS Pathog. 2019;15(7):e1007888. doi:10.1371/journal.ppat.100788831276485
   PubMed Web of Science ®Google Scholar
• Schmidt H, Hensel M. Pathogenicity islands in bacterial pathogenesis [published correction appears in Clin Microbiol Rev. 2006 Jan;19(1):257]. Clin Microbiol Rev. 2004;17(1):14–56. doi:10.1128/CMR.17.1.14-56.200414726454
   PubMed Web of Science ®Google Scholar
• Cervera-Alamar M, Guzmán-Markevitch K, Žiemytė M, et al. Mobilisation mechanism of pathogenicity islands by endogenous phages in Staphylococcus aureus clinical strains. Sci Rep. 2018;8(1):16742. doi:10.1038/s41598-018-34918-230425253
   PubMed Web of Science ®Google Scholar
• Karaolis DK, Somara S, Maneval DR, Johnson JA, Kaper JB. A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nature. 1999;399(6734):375–379. doi:10.1038/2071510360577
   PubMed Web of Science ®Google Scholar
• Novick RP, Ram G. Staphylococcal pathogenicity islands-movers and shakers in the genomic firmament. Curr Opin Microbiol. 2017;38:197–204. doi:10.1016/j.mib.2017.08.00129100762
   PubMed Web of Science ®Google Scholar
• Ram G, Chen J, Kumar K, et al. Staphylococcal pathogenicity island interference with helper phage reproduction is a paradigm of molecular parasitism. Proc Natl Acad Sci U S A. 2012;109(40):16300–16305. doi:10.1073/pnas.120461510922991467
   PubMed Web of Science ®Google Scholar
• Chen J, Novick RP. Phage-mediated intergeneric transfer of toxin genes. Science. 2009;323(5910):139–141. doi:10.1126/science.116478319119236
   PubMed Web of Science ®Google Scholar
• Tsao YF, Taylor VL, Kala S, et al. Phage morons play an important role in Pseudomonas aeruginosa phenotypes. J Bacteriol. 2018;200(22):e00189–18. doi:10.1128/JB.00189-1830150232
   PubMed Web of Science ®Google Scholar
• Asadulghani M, Ogura Y, Ooka T, et al. The defective prophage pool of Escherichia coli O157: prophage-prophage interactions potentiate horizontal transfer of virulence determinants. PLoS Pathog. 2009;5(5):e1000408. doi:10.1371/journal.ppat.100040819412337
   PubMed Web of Science ®Google Scholar
• Johnson HM, Russell JK, Pontzer CH. Staphylococcal enterotoxin microbial superantigens. FASEB J. 1991;5(12):2706–2712. doi:10.1096/fasebj.5.12.19160931916093
   PubMed Web of Science ®Google Scholar
• Krakauer T, Stiles BG. The staphylococcal enterotoxin (SE) family: SEB and siblings. Virulence. 2013;4(8):759–773. doi:10.4161/viru.2390523959032
   PubMed Web of Science ®Google Scholar
• Doub JB, Wilson E. Observed transaminitis with a unique bacteriophage therapy protocol to treat recalcitrant Staphylococcal biofilm infections [published online ahead of print, 2021 Jul 30]. Infection. 2021. doi:10.1007/s15010-021-01675-w
   Web of Science ®Google Scholar
• Abedon ST, Danis-Wlodarczyk KM, Alves DR. Phage therapy in the 21st century: is there modern, clinical evidence of phage-mediated efficacy? Pharmaceuticals. 2021;14(11):1157. doi:10.3390/ph1411115734832939
   PubMed Web of Science ®Google Scholar
• Sander M, Schmieger H. Method for host-independent detection of generalized transducing bacteriophages in natural habitats. Appl Environ Microbiol. 2001;67(4):1490–1493. doi:10.1128/AEM.67.4.1490-1493.200111282595
   PubMed Web of Science ®Google Scholar
• Beumer A, Robinson JB. A broad-host-range, generalized transducing phage (SN-T) acquires 16S rRNA genes from different genera of bacteria. Appl Environ Microbiol. 2005;71(12):8301–8304. doi:10.1128/AEM.71.12.8301-8304.200516332816
   PubMed Web of Science ®Google Scholar
• Del Casale A, Flanagan PV, Larkin MJ, Allen CC, Kulakov LA. Extent and variation of phage-borne bacterial 16S rRNA gene sequences in wastewater environments. Appl Environ Microbiol. 2011;77(15):5529–5532. doi:10.1128/AEM.00457-1121666016
   PubMed Web of Science ®Google Scholar
• Alexeeva S, Guerra Martínez JA, Spus M, Smid EJ. Spontaneously induced prophages are abundant in a naturally evolved bacterial starter culture and deliver competitive advantage to the host. BMC Microbiol. 2018;18(1):120. doi:10.1186/s12866-018-1229-130249194
   PubMed Web of Science ®Google Scholar
• Mašlaňová I, Stříbná S, Doškař J, Pantůček R. Efficient plasmid transduction to Staphylococcus aureus strains insensitive to the lytic action of transducing phage. FEMS Microbiol Lett. 2016;363(19):fnw211. doi:10.1093/femsle/fnw21127609232
   PubMed Web of Science ®Google Scholar
• Yue WF, Du M, Zhu MJ. High temperature in combination with UV irradiation enhances horizontal transfer of stx2 gene from E. coli O157: H7to non-pathogenic E. coli. PLoS One. 2012;7(2):e31308. doi:10.1371/journal.pone.003130822347461
   PubMed Web of Science ®Google Scholar
• Pinchuk IV, Beswick EJ, Reyes VE. Staphylococcal enterotoxins. Toxins (Basel). 2010;2(8):2177–2197. doi:10.3390/toxins208217722069679
   PubMed Web of Science ®Google Scholar
• Van Tyne D, Martin MJ, Gilmore MS. Structure, function, and biology of the Enterococcus faecalis cytolysin. Toxins (Basel). 2013;5(5):895–911. doi:10.3390/toxins505089523628786
   PubMed Web of Science ®Google Scholar
• Lau GW, Hassett DJ, Britigan BE. Modulation of lung epithelial functions by Pseudomonas aeruginosa. Trends Microbiol. 2005;13(8):389–397. doi:10.1016/j.tim.2005.05.01115951179
   PubMed Web of Science ®Google Scholar
• Marshall JC. Endotoxin in the pathogenesis of sepsis. Contrib Nephrol. 2010;167:1–13.20519894
   PubMed Web of Science ®Google Scholar
• Kissner TL, Cisney ED, Ulrich RG, Fernandez S, Saikh KU. Staphylococcal enterotoxin A induction of pro-inflammatory cytokines and lethality in mice is primarily dependent on MyD88. Immunology. 2010;130(4):516–526. doi:10.1111/j.1365-2567.2010.03249.x20465563
   PubMed Web of Science ®Google Scholar
• Janik E, Ceremuga M, Saluk-Bijak J, Bijak M. Biological toxins as the potential tools for bioterrorism. Int J Mol Sci. 2019;20(5):1181. doi:10.3390/ijms20051181
   Web of Science ®Google Scholar
• Rusnak JM, Kortepeter MG, Ulrich R, et al. Laboratory exposures to staphylococcal enterotoxin B. Emerg Infect Dis. 2004;10(9):1544–1549. doi:10.3201/eid1009.04025015498154
   PubMed Web of Science ®Google Scholar
• Meyrand A, Boutrand-Loei S, Ray-Gueniot S, et al. Growth and enterotoxin production of Staphylococcus aureus during the manufacture and ripening of Camembert-type cheeses from raw goats’ milk. J Appl Microbiol. 1998;85(3):537–544. doi:10.1046/j.1365-2672.1998.853531.x9750284
   PubMed Web of Science ®Google Scholar
• Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS. Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol. 2013;28(11):2097–2105. doi:10.1007/s00467-012-2383-623288350
   PubMed Web of Science ®Google Scholar
• Chesney PJ, Crass BA, Polyak MB, et al. Toxic shock syndrome: management and long-term sequelae. Ann Intern Med. 1982;96(6 Pt 2):847–851. doi:10.7326/0003-4819-96-6-8477091955
   PubMed Web of Science ®Google Scholar
• Löfblom J, Rosenstein R, Nguyen MT, Ståhl S, Götz F. Staphylococcus carnosus: from starter culture to protein engineering platform. Appl Microbiol Biotechnol. 2017;101(23–24):8293–8307. doi:10.1007/s00253-017-8528-628971248
   PubMed Web of Science ®Google Scholar
• Nair D, Memmi G, Hernandez D, et al. Whole-genome sequencing of Staphylococcus aureus strain RN4220, a key laboratory strain used in virulence research, identifies mutations that affect not only virulence factors but also the fitness of the strain. J Bacteriol. 2011;193(9):2332–2335. doi:10.1128/JB.00027-1121378186
   PubMed Web of Science ®Google Scholar
• Rodríguez-Rubio L, Serna C, Ares-Arroyo M, et al. Extensive antimicrobial resistance mobilization via multicopy plasmid encapsidation mediated by temperate phages. J Antimicrob Chemother. 2020;75(11):3173–3180. doi:10.1093/jac/dkaa31132719862
   PubMed Web of Science ®Google Scholar
• Hay ID, Lithgow T. Filamentous phages: masters of a microbial sharing economy. EMBO Rep. 2019;20(6):e47427. doi:10.15252/embr.20184742730952693
   PubMed Web of Science ®Google Scholar
• Faruque SM, Mekalanos JJ. Phage-bacterial interactions in the evolution of toxigenic Vibrio cholerae. Virulence. 2012;3(7):556–565. doi:10.4161/viru.2235123076327
   PubMed Web of Science ®Google Scholar
• Wolcott R, Costerton JW, Raoult D, Cutler SJ. The polymicrobial nature of biofilm infection. Clin Microbiol Infect. 2013;19(2):107–112. doi:10.1111/j.1469-0691.2012.04001.x22925473
   PubMed Web of Science ®Google Scholar
• Orazi G, O’Toole GA. “It takes a village”: mechanisms underlying antimicrobial recalcitrance of polymicrobial biofilms. J Bacteriol. 2019;202(1):e00530–19. doi:10.1128/JB.00530-1931548277
   PubMed Web of Science ®Google Scholar
• Jean-Pierre F, Vyas A, Hampton TH, Henson MA, O’Toole GA. One versus many: polymicrobial communities and the cystic fibrosis airway. mBio. 2021;12(2):e00006–21. doi:10.1128/mBio.00006-2133727344
   PubMed Web of Science ®Google Scholar
• Sibley CD, Surette MG. The polymicrobial nature of airway infections in cystic fibrosis: cangene gold medal lecture. Can J Microbiol. 2011;57(2):69–77. doi:10.1139/W10-10521326348
   PubMed Web of Science ®Google Scholar
• Noor S, Zubair M, Ahmad J. Diabetic foot ulcer–a review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr. 2015;9(3):192–199. doi:10.1016/j.dsx.2015.04.00725982677
   PubMedGoogle Scholar
• Azam AH, Tanji Y. Peculiarities of Staphylococcus aureus phages and their possible application in phage therapy. Appl Microbiol Biotechnol. 2019;103(11):4279–4289. doi:10.1007/s00253-019-09810-230997551
   PubMed Web of Science ®Google Scholar
• Secor PR, Sweere JM, Michaels LA, et al. Filamentous bacteriophage promote biofilm assembly and function. Cell Host Microbe. 2015;18(5):549–559. doi:10.1016/j.chom.2015.10.01326567508
   PubMed Web of Science ®Google Scholar
• Pires DP, Melo LDR, Azeredo J. Understanding the complex phage-host interactions in biofilm communities. Annu Rev Virol. 2021;8(1):73–94. doi:10.1146/annurev-virology-091919-07422234186004
   PubMed Web of Science ®Google Scholar
• Wilson GG, Young KY, Edlin GJ, Konigsberg W. High-frequency generalised transduction by bacteriophage T4. Nature. 1979;280(5717):80–82. doi:10.1038/280080a015305587
   PubMed Web of Science ®Google Scholar